Daniel P. Florin - Jun 25, 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Daniel Philip Florin
Stock symbol
LUNG
Transactions as of
Jun 25, 2021
Transactions value $
$98,035
Form type
4
Date filed
6/28/2021, 05:33 PM
Previous filing
Jun 11, 2021
Next filing
Jul 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Purchase $98K +2.22K +79.07% $44.12 5.03K Jun 25, 2021 Direct F1, F2
holding LUNG Common Stock 15.8K Jun 25, 2021 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.68 to $44.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 The shares are directly held by Kelly A Florin Trust, for which the Reporting Person is a trustee.